We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Ultrasound Technology Helps Dissolve Blood Clots

By MedImaging International staff writers
Posted on 19 Jun 2014
Print article
Image: The EkoSonic IDDC and removable coaxial ultrasound transducer core (Photo courtesy of EKOS Corporation).
Image: The EkoSonic IDDC and removable coaxial ultrasound transducer core (Photo courtesy of EKOS Corporation).
A new system allows controlled and selective infusion of physician-specified fluids, including thrombolytics, for the treatment of pulmonary embolism (PE).

The EkoSonic Endovascular System is an ultrasound-facilitated catheter-directed low-dose fibrinolysis device designed to gently accelerate the penetration of thrombolytic agents into a thrombus, providing high levels of lysis to minimize the risk of PE and intracranial hemorrhage. The system is intended for the treatment of patients with a 50% or more clot burden in one or both main pulmonary arteries or lobar pulmonary arteries, as well as evidence of right heart dysfunction, based on a mean pulmonary artery pressure of 25 mmHg or higher, and/or echocardiographic evaluation.

The device consists of a multilumen intelligent drug delivery catheter (IDDC) with a removable coaxial ultrasound transducer core and a microsonic device (MSD). The acoustic energy conditions the clot by thinning fibrin and increasing porosity, creating a pressure gradient which transports the thrombolytic agent deep into the thrombus. As a result, there is no thrombus fracture or breakage, no damage to valves or the vascular wall, and no hemolysis.

An added benefit is that since red blood cells (RBCs) are not fractured during the procedure, there is no adenosine release and no additional compromise to renal function. The EkoSonic Endovascular System is a product of EKOS Corporation (Bothell, WA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The EKOS clinical data established that patients stricken with a life-threatening pulmonary embolism can be successfully and safely treated with the EkoSonic system,” said Prof. Samuel Goldhaber, MD, director of the Thrombosis Research Group at Brigham and Woman’s Hospital (Boston, MA, USA). “This is the first FDA cleared treatment option for PE since the approval of the drug tissue plasminogen activator [tPA], in 1990.”

“Interventional radiologists, cardiologists, cardiothoracic and vascular surgeons at leading institutions around the world use our system to provide faster, safer and more complete dissolution of thrombus,” said Matt Stupfel, General Manager of EKOS. “We are proud to have completed the world’s only randomized controlled trial and the largest prospective single-arm trial on the safety and effectiveness of EKOS therapy in the treatment of PE. The positive outcomes of those trials, combined with our expanded indication will allow a better standard of care for thousands of patients who suffer from PE.”

Related Links:

EKOS Corporation

Gold Supplier
Premium Ultrasound Scanner
Crossover Angiography System
Trinias C16s/C12s/F12s
Mammography Illuminator
High Frequency X-Ray Generator

Print article



view channel
Image: New scan measures tumor oxygen levels in real-time to help guide treatment (Photo courtesy of ICR)

Oxygen-Enhanced MRI Technology Allows Cancer Doctors to See Inside Tumors

Since the 1950s, researchers have been aware of the difficulty in effectively treating tumors deprived of oxygen, a problem that is further exacerbated when treating them with radiotherapy.... Read more


view channel
Image: New focused ultrasound is effective for treating Parkinson’s, movement disorders (Photo courtesy of Pexels)

New Focused Ultrasound Treatment Proves Effective for Parkinson’s Disease Patients

Parkinson's disease is a neurological condition characterized by the loss of dopamine neurons within the brain. While medications such as levodopa can be effective in managing this condition, some patients... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

General/Advanced Imaging

view channel
Image: Viz.ai is the first to receive FDA 510(k) clearance for an AI algorithm for abdominal aortic aneurysm (Photo courtesy of Pexels)

AI Algorithm Flags and Triages Suspected Abdominal Aortic Aneurysms from Chest CT Scans

An abdominal aortic aneurysm (AAA) denotes a bulge in the abdominal aorta, the chief artery that transfers blood from the heart to other parts of the body. If not detected and treated in time, AAA can... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.